Primary lymphoma of the breast.Ultrastructural study of two cases

Navas, J. J.; Battifora, Hector

doi:10.1002/1097-0142(197705)39:5<2025::aid-cncr2820390519>3.0.co;2-0

Cited by 23 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A rare diagnosis, PBL accounts for less than 1% of breast malignancies and less than 2% of extranodal nonHodgkin lymphomas (NHLs) (2,(4)(5)(6)(7)(8). PBL is more aggressive and has a worse prognosis in comparison to that of extranodal NHL of alternate sites, such as in the gastrointestinal tract (9)(10)(11)(12). SBL (3,7,(18)(19)(20)(21)(22)(23).…”

Section: Introductionmentioning

confidence: 99%

Primary and Secondary Breast Lymphoma: Clinical, Pathologic, and Multimodality Imaging Review

et al. 2019

View full text Add to dashboard Cite

Breast lymphoma is a rare hematologic neoplasm that originates in the breast lymphoid tissue and includes primary breast lymphoma (PBL) and secondary breast lymphoma (SBL). PBL involves the breast lymphoid tissue in the absence of previously identified extra mammary lymphoma and widespread disease. SBL is the most common metastasis to the breast, accounting for 17% of metastatic disease to the breast. PBL and SBL usually demonstrate imaging phenotypes that overlap with those of primary breast carcinoma, which makes a prospective diagnosis of breast lymphoma challeng ing. These nonspecific imaging features include an iso to hyper dense oval mass or masses at mammography, a hypoechoic or mixedechogenicity hypervascular mass at US, an enhancing mass with type II kinetics at MRI, and high fluorine 18-fluorodeoxyglu cose avidity at PET. In cases of suspected lymphoma, reviewing the clinical history, using appropriate biopsy techniques, and evaluating for multiplicity, bilaterality, and distant disease are critical for diag nosis and management. A patient with PBL generally has an earlier clinical presentation with a palpable abnormality and a solitary im aging finding. In contrast, multiple masses in an older patient and an occult clinical presentation favor an SBL diagnosis. ©

show abstract

Section: Introductionmentioning

confidence: 99%

Primary and Secondary Breast Lymphoma: Clinical, Pathologic, and Multimodality Imaging Review

et al. 2019

View full text Add to dashboard Cite

show abstract

“…To date, the role of surgery in the management of PBL is still a matter of debate. Because fineneedle aspiration cytology is the method of choice for the diagnosis of breast tumor, the role of surgery has become less important than in the past, and some authors feel that surgical procedures are probably not indicated any more [32]. However, all our patients underwent a surgical approach always including ipsilateral axillary dissection, although a diagnosis of breast carcinoma had been previously excluded.…”

Section: Discussionmentioning

confidence: 99%

Primary breast lymphoma: outcome of 7 patients and a review of the literature

Vigliotti

Dell'Olio

Sala

et al. 2005

Leukemia & Lymphoma

View full text Add to dashboard Cite

Primary breast lymphomas (PBL) are uncommon neoplasms. Seven PBL were diagnosed between March 1993 and October 2002. A lumpectomy (n=4) or radical mastectomy (n=3) was performed; 5 patients were in clinical stage (CS) II and 2 in CS IV; 6 patients received the CEOP regimen (cyclophosphamide, vincristine, epirubicin and prednisone) after surgery and 4 also had additional radiotherapy; 1 patient did not receive any treatment after local excision. Five patients (71%) achieved complete remission and 2 (29%) partial remission, with an overall response rate of 100%. All remitter patients are alive and well after a median follow-up of 75 months (range 10--121 months). Two patients in partial remission died of progressive disease. After a median follow-up of 99 months (range 84--111 months) for surviving patients, the 10 year overall and disease-free survival rates are both 71%, with 5 patients well and still free of disease. We conclude that the optimal sequence of full-dose anthracycline-containing regimens and radiation therapy should be the treatment of choice for patients with PBL.

show abstract

“…Primary breast lymphoma accounts for between 0.04 % and 0.5 % of all malignant breast tumors and 2.2 % of all extranodal lymphomas [1] and comprises between 0.04 % and 0.53 % of all mammary malignancies [2,4,6,9,10,11,12].…”

Section: Discussionmentioning

confidence: 99%

Low-grade mucosa-associated lymphoma of the breast: radiological–pathological correlation

et al. 2001

View full text Add to dashboard Cite

Primary breast lymphoma generally is a rare disease. We present a case of a low-grade mucosa-associated (MALT) lymphoma of the breast in a 32-year-old woman, a distinctive type of localized non-Hodgkin's lymphoma (NHL), which is very seldom located in the breast. We performed differential diagnosis and radiological-pathological correlation with regard to typical microscopic criteria and clinical relevance that apply for that special entity.

show abstract

Primary lymphoma of the breast.Ultrastructural study of two cases

Cited by 23 publications

References 22 publications

Primary and Secondary Breast Lymphoma: Clinical, Pathologic, and Multimodality Imaging Review

Primary and Secondary Breast Lymphoma: Clinical, Pathologic, and Multimodality Imaging Review

Primary breast lymphoma: outcome of 7 patients and a review of the literature

Low-grade mucosa-associated lymphoma of the breast: radiological–pathological correlation

Contact Info

Product

Resources

About